Ara
Toplam kayıt 7, listelenen: 1-7
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds
(Elsevier Science Inc, 2020)
BACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results ...
Impact of bioresorbable scaffold use on procedural features compared with new-generation drug-eluting stents
(Kartal Koşuyolu High Specialization Training and Research Hospital, 2020)
Introduction: Although bioresorbable scaffolds (BRS) are considered a new paradigm in stent technology, operators are often discouraged from implanting BRS because of increased strut thickness, reduced radial force, ...
Acute left main coronary artery occlusion following transcatheter aortic valve replacement without obvious risk factors of coronary obstruction
(Turkish Society of Cardiology, 2020)
Transcatheter aortic valve implantation (TAVI) has emerged as a prominent alternative for patients with severe aortic stenosis, who are deemed to be at a greater risk for surgical interventions (1). However, extreme caution ...
Cystatin C and uncontrolled hypertension
(Turkish Society of Cardiology, 2020)
Objective: Increased serum level of cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. We investigated the predictive value of serum cystatin C for controlling hypertension ...
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)
Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ...
Improvement of endothelial function early after thrombolytic therapy in patients with prosthetic heart valve thrombosis
(Turkish Society of Cardiology, 2020)
Objective: Prosthetic valve thrombosis (PVT) is a serious complication among patients with prosthetic heart valves. Thrombolytic therapy (TT) is now widely used as first-line treatment for PVT. Endothelial dysfunction has ...